Stockscreener 앱 받기
36.59
0.95%
-0.41
시간 외 거래:
36.53
-0.06
-0.16%
전일 마감가:
$37.00
열려 있는:
$36.52
하루 거래량:
664.52K
Relative Volume:
0.66
시가총액:
$4.12B
수익:
$14.09M
순이익/손실:
$-176.94M
주가수익비율:
-17.02
EPS:
-2.15
순현금흐름:
$-141.24M
1주 성능:
+1.41%
1개월 성능:
+19.50%
6개월 성능:
+82.98%
1년 성능:
+103.27%
1일 변동 폭
$36.34
$37.88
1주일 범위
$35.50
$39.03
52주 변동 폭
$14.06
$41.47
Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile
명칭
Newamsterdam Pharma Company Nv
전화
35 206 2971
주소
GOOIMEER 2-35, NARRDEN
NAMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NAMS
Newamsterdam Pharma Company Nv
|
36.61 | 4.17B | 14.09M | -176.94M | -141.24M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.80 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.77 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.84 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.74 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 재개 | H.C. Wainwright | Buy |
| 2025-08-25 | 개시 | Wells Fargo | Overweight |
| 2025-07-17 | 개시 | Goldman | Neutral |
| 2025-06-17 | 개시 | Citigroup | Buy |
| 2025-06-10 | 개시 | Stifel | Buy |
| 2025-06-04 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-05-15 | 개시 | TD Cowen | Buy |
| 2024-03-14 | 개시 | Scotiabank | Sector Outperform |
| 2024-01-18 | 개시 | Guggenheim | Buy |
| 2024-01-16 | 개시 | Piper Sandler | Overweight |
| 2023-10-30 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Newamsterdam Pharma Company Nv 주식(NAMS)의 최신 뉴스
Is NewAmsterdam Pharma Company N.V. stock poised for growth2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock recover faster than marketMarket Trend Review & Community Shared Stock Ideas - newser.com
Pattern recognition hints at NewAmsterdam Pharma Company N.V. upside2025 Trading Volume Trends & High Accuracy Swing Trade Signals - newser.com
Using economic indicators to assess NewAmsterdam Pharma Company N.V. Equity Warrant potential2025 Retail Activity & High Return Stock Watch Alerts - newser.com
Is NewAmsterdam Pharma Company N.V. (KH6) stock attractive post correctionQuarterly Profit Summary & Risk Controlled Daily Plans - newser.com
What candlestick patterns are forming on NewAmsterdam Pharma Company N.V. Equity WarrantEntry Point & Safe Capital Investment Plans - newser.com
Can NewAmsterdam Pharma Company N.V. Equity Warrant stock withstand economic slowdownTrade Entry Summary & Entry Point Strategy Guides - newser.com
Can a trend reversal in NewAmsterdam Pharma Company N.V. Equity Warrant lead to recoveryJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
Is NewAmsterdam Pharma Company N.V. (KH6) stock undervalued by metrics2025 Key Highlights & Precise Buy Zone Tips - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock a top pick in earnings season2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock compares to market leaders2025 Volatility Report & Reliable Trade Execution Plans - newser.com
Is NewAmsterdam Pharma Company N.V. stock a good choice for value investors2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com
Why NewAmsterdam Pharma Company N.V. stock is seen as undervaluedRate Cut & Weekly High Potential Stock Alerts - newser.com
Assessing NewAmsterdam Pharma (NasdaqGM:NAMS) Valuation Ahead of Major Phase 3 Data Presentations - simplywall.st
NewAmsterdam Pharma Company N.V. recovery potential after sell offWeekly Profit Report & High Accuracy Swing Entry Alerts - newser.com
Advanced analytics toolkit walkthrough for NewAmsterdam Pharma Company N.V. Equity WarrantQuarterly Growth Report & Daily Momentum Trading Reports - newser.com
How to escape a deep drawdown in NewAmsterdam Pharma Company N.V.Weekly Risk Report & Community Consensus Trade Signals - newser.com
Why retail investors pile into NewAmsterdam Pharma Company N.V. Equity Warrant stockWeekly Stock Summary & Free Expert Verified Stock Movement Alerts - newser.com
Can NewAmsterdam Pharma Company N.V. (KH6) stock surprise markets with earningsWall Street Watch & Low Drawdown Trading Strategies - newser.com
Visual analytics tools that track NewAmsterdam Pharma Company N.V. Equity Warrant performanceMarket Performance Summary & Fast Entry Momentum Alerts - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock performs in stagflation2025 Market Outlook & AI Driven Stock Movement Reports - newser.com
Can technical indicators confirm NewAmsterdam Pharma Company N.V. Equity Warrant’s reversalWeekly Trend Summary & Low Risk Entry Point Guides - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock reacts to oil pricesJuly 2025 Levels & Verified Chart Pattern Trade Signals - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock benefit from upcoming earnings reports2025 Trading Volume Trends & Accurate Entry/Exit Alerts - newser.com
How hedge fund analytics apply to NewAmsterdam Pharma Company N.V. stock2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com
Will earnings trigger a reversal in NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Trends & Safe Investment Capital Preservation Plans - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock maintain momentum in 2025Share Buyback & Technical Entry and Exit Tips - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock trading at a premium valuationJuly 2025 Final Week & Reliable Momentum Entry Alerts - newser.com
Is NewAmsterdam Pharma Company N.V. (KH6) stock prepared for digital transitionMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com
Can volume confirm reversal in NewAmsterdam Pharma Company N.V. Equity WarrantMarket Rally & Community Verified Watchlist Alerts - newser.com
Technical analysis overview for NewAmsterdam Pharma Company N.V. Equity Warrant stockWeekly Market Report & Community Consensus Picks - newser.com
Risk adjusted return profile for NewAmsterdam Pharma Company N.V. Equity Warrant analyzed2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Key resistance and support levels for NewAmsterdam Pharma Company N.V.July 2025 Opening Moves & Intraday High Probability Alerts - newser.com
Using data models to predict NewAmsterdam Pharma Company N.V. Equity Warrant stock movement2025 Top Decliners & AI Driven Stock Reports - newser.com
NewAmsterdam Pharma Hits Day High with 8.05% Surge, Strong Intraday Performance - Markets Mojo
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock bottoming outBuy Signal & Fast Moving Stock Watchlists - newser.com
What does recent volatility data suggest for NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Setups & Expert-Curated Trade Recommendations - newser.com
Published on: 2025-11-02 01:19:15 - newser.com
Newamsterdam Pharma Company Nv (NAMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):